← Open Payments lookup

DENISE VIEKMAN: Open Payments

NPI 1295789329 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,097 in 142 payments from 19 companies in 2025. Trend: 2023 $3,559 · 2024 $3,607 · 2025 $4,097

Food & beverage: $4,044Education: $53
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP35$1,300
Regeneron Healthcare Solutions, Inc.24$851
GENZYME CORPORATION14$468
Takeda Pharmaceuticals U.S.A., Inc.13$298
ARS Pharmaceuticals Operations, Inc.10$273
GlaxoSmithKline, LLC.14$210
Novartis Pharmaceuticals Corporation12$171
Amgen Inc.4$100
Verona Pharma, Inc.2$53
SANOFI-AVENTIS U.S. LLC1$53

Products named: DUPIXENT, FASENRA, TEZSPIRE, NEFFY, AIRSUPRA, CUVITRU, NUCALA, BREZTRI.

Industry payments across ME — which companies pay providers there.